In a letter to the SEC, T. Rowe Price (TROW) expressed "significant concerns" with proposed regulatory changes that would "sacrifice the objectivity" of proxy advisory research or delay the voting process. And T. Rowe warned that the proposed changes could allow companies to "inappropriately influence" this research.